Presenter: Lisa Shaver, ND, LAc

Original Date: November 6, 2021

Gluten became a household word in the 2000’s along with the revelation that celiac disease is a common condition, more common than rheumatoid arthritis. Despite the prevalence figures, celiac disease continues to be underdiagnosed in the US. Perhaps 6 out of every 50 patients you see has celiac disease. Sadly, we have only succeeded in diagnosing an estimated 20% of all celiacs in the United States.

Research continues robustly, and the complexities of this permanent autoimmune inflammatory disease continue to be revealed. Dr Shaver will guide you on an update of the recent research on celiac disease touching on the microbiome, viral and bacterial risk factors, inflammatory implications and presentation.

Research on pharmaceutical investigative treatment candidates in phase II/III clinical trials will be discussed.

0.25 pharmacy and 1.25 general CEUs approved by OBNM